Evidence map›Paper›PMID 40223153›Full record

ArticleScientific reports2025

Explainable AI for lung cancer detection via a custom CNN on CT images.

Mohamed Hammad, Mohammed ElAffendi, Ahmed A Abd El-Latif, Abdelhamied A Ateya, Gauhar Ali, Pawel Plawiak

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed HammadEIAS Data Science Lab, College of Computer and Information Sciences, Center of Excellence in Quantum and Intelligent Computing, Prince Sultan University, Riyadh, 11586, Saudi Arabia. mhammad@psu.edu.sa.
Mohammed ElAffendiEIAS Data Science Lab, College of Computer and Information Sciences, Center of Excellence in Quantum and Intelligent Computing, Prince Sultan University, Riyadh, 11586, Saudi Arabia.
Ahmed A Abd El-LatifEIAS Data Science Lab, College of Computer and Information Sciences, Center of Excellence in Quantum and Intelligent Computing, Prince Sultan University, Riyadh, 11586, Saudi Arabia.
Abdelhamied A AteyaEIAS Data Science Lab, College of Computer and Information Sciences, Center of Excellence in Quantum and Intelligent Computing, Prince Sultan University, Riyadh, 11586, Saudi Arabia.
Gauhar AliEIAS Data Science Lab, College of Computer and Information Sciences, Center of Excellence in Quantum and Intelligent Computing, Prince Sultan University, Riyadh, 11586, Saudi Arabia.
Pawel PlawiakDepartment of Computer Science, Faculty of Computer Science and Telecommunications, Cracow University of Technology, Warszawska 24 Str., Kraków, 31-155, Poland. plawiak.pawel@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer, which claims 1.8 million lives annually, is still one of the leading causes of cancer-related deaths globally. Patients with lung cancer frequently have a bad prognosis because of late-stage detection, which severely limits treatment options and decreases survival rates. Early detection is essential for better outcomes, but traditional CT image analysis is time-consuming, prone to error, and relies on subjective judgments. To overcome these issues, we propose a custom convolutional neural network (CNN) combined with explainable AI (XAI) techniques, particularly gradient-weighted class activation mapping (Grad-CAM). This approach is intended to reliably classify lung cancer into squamous cell carcinoma, large cell carcinoma, or adenocarcinoma. Unlike conventional methods, our approach not only achieves highly accurate classification of lung cancer subtypes but also incorporates clinically validated interpretability features to ensure alignment with medical diagnostics. Our model trained on a comprehensive dataset of CT images achieved an overall accuracy of 93.06%. This performance demonstrates the model's robustness in detecting even subtle malignancies, with strong precision, recall, and F1-scores across all cancer types. Including interpretable Grad-CAM visualizations ensures reliability and transparency, aiding clinicians in understanding the model's predictions. This innovative method demonstrates the potential to revolutionize early lung cancer detection and improve patient survival rates by combining state-of-the-art accuracy with explainability tailored for clinical application.

Indexed as

Image Processing, Computer-AssistedLung NeoplasmsNeural Networks, ComputerTomography, X-Ray ComputedEarly Detection of CancerHumansCNNCT imagesExplainable AIGrad-CAMLung cancer detectionMedical imaging

Identifiers

PMID40223153
PMCPMC11994823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.